Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Fisher

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|September 1, 1977
Anthelmintic dihydroquinoxalino[2,3-b]quinoxalinesM H Fisher, A Lusi, J R Egerton
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1981
Cholesterol inhibition of streptolysin O toxicity for myocardial cells in tissue cultureM H Fisher, E L Kaplan, L W Wannamaker
Journal of Intellectual Disability Research : JIDR|June 9, 2016
Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndromeM H Fisher, M D Lense, E M Dykens
Journal of Medicinal Chemistry|January 1, 1977
5,11-dimethyl-2,9-bis(phenylacetyl)-5,11-diazatetracyclo[6.2.2.0(2,7).0(4,9)]dodecane, a potent, novel analgesicM H Fisher, E J Grabowski, A A Patchett, et al.
Cancer Letters|May 24, 1991
Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanismsY Shoji, M H Fisher, A Periasamy, et al.
The Journal of Antibiotics|August 1, 1989
Brine shrimp (Artemia salina) as a convenient bioassay for avermectin analogsT A Blizzard, C L Ruby, H Mrozik, et al.
Journal of Medicinal Chemistry|June 1, 1982
Avermectin acyl derivatives with anthelmintic activityH Mrozik, P Eskola, M H Fisher, et al.
Science (New York, N.Y.)|August 26, 1983
Ivermectin: a potent new antiparasitic agentW C Campbell, M H Fisher, E O Stapley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expressionS K Alahari, R DeLong, M H Fisher, et al.
Biochemical Pharmacology|November 1, 1989
Characterization of a novel inhibitor of human DNA polymerases: 3,4,5-tri-O-galloylquinic acidW B Parker, M Nishizawa, M H Fisher, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|September 1, 1977
Anthelmintic dihydroquinoxalino[2,3-b]quinoxalinesM H Fisher, A Lusi, J R Egerton
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1981
Cholesterol inhibition of streptolysin O toxicity for myocardial cells in tissue cultureM H Fisher, E L Kaplan, L W Wannamaker
Journal of Intellectual Disability Research : JIDR|June 9, 2016
Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndromeM H Fisher, M D Lense, E M Dykens
Journal of Medicinal Chemistry|January 1, 1977
5,11-dimethyl-2,9-bis(phenylacetyl)-5,11-diazatetracyclo[6.2.2.0(2,7).0(4,9)]dodecane, a potent, novel analgesicM H Fisher, E J Grabowski, A A Patchett, et al.
Cancer Letters|May 24, 1991
Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanismsY Shoji, M H Fisher, A Periasamy, et al.
The Journal of Antibiotics|August 1, 1989
Brine shrimp (Artemia salina) as a convenient bioassay for avermectin analogsT A Blizzard, C L Ruby, H Mrozik, et al.
Journal of Medicinal Chemistry|June 1, 1982
Avermectin acyl derivatives with anthelmintic activityH Mrozik, P Eskola, M H Fisher, et al.
Science (New York, N.Y.)|August 26, 1983
Ivermectin: a potent new antiparasitic agentW C Campbell, M H Fisher, E O Stapley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expressionS K Alahari, R DeLong, M H Fisher, et al.
Biochemical Pharmacology|November 1, 1989
Characterization of a novel inhibitor of human DNA polymerases: 3,4,5-tri-O-galloylquinic acidW B Parker, M Nishizawa, M H Fisher, et al.
Pageof 8